ZKB/PUT/ROCHE GS/240/0.02/28.06.24 Share Price

Warrant

ROGS2Z

CH1268386898

Real-time Bid/Ask 08:26:32 03/06/2024 BST
0.19 CHF / 0.2 CHF -2.50% Intraday chart for ZKB/PUT/ROCHE GS/240/0.02/28.06.24
1 month-50.00%
3 months-45.95%
Date Price Change
31/05/24 0.2 -20.00%
30/05/24 0.25 +4.17%
28/05/24 0.24 +9.09%

Delayed Quote Swiss Exchange

Last update May 31, 2024 at 04:20 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying ROCHE HOLDING AG
Issuer ZKB
ROGS2Z
ISINCH1268386898
Date issued 06/09/2023
Strike 240 CHF
Maturity 28/06/2024 (26 Days)
Parity 50 : 1
Emission price 0.25 CHF
Emission volume N/A
Settlement Beides
Currency CHF

Technical Indicators

Highest since issue 0.52 CHF
Lowest since issue 0.15 CHF
Spread 0.01 CHF
Spread %5.00%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
231 CHF
Average target price
277.5 CHF
Spread / Average Target
+20.14%
Consensus
  1. Stock Market
  2. Warrants
  3. ROGS2Z Warrant
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW